Dolby Laboratories Inc

For the period ended Sep 27, 2024. Filed Nov 19, 2024.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Nov 19, 2024

DLB$64.79-0.1%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Balance Sheets

(in thousands, except share and per share amounts)

	September 27,2024	September 29,2023
ASSETS
Current assets:
Cash and cash equivalents	$482,047	$745,364
Restricted cash	95,705	72,602
Short-term investments	—	139,148
Accounts receivable, net of allowance for credit losses of $5,361 and $9,683	315,465	262,245
Contract assets, net of allowance for credit losses of $106 and $138	197,478	182,130
Inventories, net	33,728	35,623
Prepaid expenses and other current assets	69,994	50,692
Total current assets	1,194,417	1,487,804
Long-term investments	89,267	97,812
Property, plant, and equipment, net	479,109	481,581
Operating lease right-of-use assets	39,046	40,199
Intangible assets, net	434,514	167,427
Goodwill	533,208	408,409
Deferred taxes	219,758	201,860
Other non-current assets	120,609	94,674
Total assets	$3,109,928	$2,979,766
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$17,380	$20,925
Accrued liabilities	347,529	351,399
Income taxes payable	9,045	4,769
Contract liabilities	31,644	31,505
Operating lease liabilities	12,238	13,628
Total current liabilities	417,836	422,226
Non-current contract liabilities	34,593	39,997
Non-current operating lease liabilities	34,754	37,020
Other non-current liabilities	135,852	108,339
Total liabilities	623,035	607,582
Commitments and Contingencies (See Note 14)
Stockholders’ equity:
Class A, $0.001 par value, one vote per share, 500,000,000 shares authorized: 59,722,442 shares issued and outstanding as of September 27, 2024 and 59,673,633 as of September 29, 2023	53	53
Class B, $0.001 par value, ten votes per share, 500,000,000 shares authorized: 35,670,779 shares issued and outstanding as of September 27, 2024 and 36,085,779 as of September 29, 2023	41	41
Retained earnings	2,496,255	2,391,990
Accumulated other comprehensive loss	(19,187)	(36,984)
Total stockholders’ equity – Dolby Laboratories, Inc.	2,477,162	2,355,100
Noncontrolling interest	9,731	17,084
Total stockholders’ equity	2,486,893	2,372,184
Total liabilities and stockholders’ equity	$3,109,928	$2,979,766

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.